Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205.7 USD | +1.33% | -2.07% | -18.22% |
Apr. 17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
Apr. 12 | Penumbra, Inc. : The underdog in healthcare |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.22% | 7.86B | |
+72.39% | 12.33B | |
+16.84% | 7.11B | |
+3.48% | 5.77B | |
+8.16% | 5.1B | |
+19.97% | 4.29B | |
-20.59% | 3.92B | |
-42.79% | 2.2B | |
+0.87% | 1.92B | |
+0.09% | 1.76B |
- Stock Market
- Equities
- PEN Stock
- News Penumbra, Inc.
- Penumbra : Citigroup Adjusts Price Target on Penumbra to $325 From $255, Maintains Buy Rating